Activity and safety of avelumab in high-grade neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas progressive after chemotherapy (AveNEC trial)
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
1 March 2025
|
| In: |
Clinical cancer research
Year: 2025, Volume: 31, Issue: 5, Pages: 860-867 |
| ISSN: | 1557-3265 |
| DOI: | 10.1158/1078-0432.CCR-24-2461 |
| Online Access: | Resolving-System, lizenzpflichtig: https://doi.org/10.1158/1078-0432.CCR-24-2461 |
| Author Notes: | Christian Fottner, Leonidas Apostolidis, Sebastian Krug, Anja Rinke, Barbara Grün, Patrick Michl, Thomas M. Gress, Daniel-Christoph Wagner, Wilfried Roth, Esther Mettler, Jana Topsch, Christian Ruckes, Peter R. Galle, and Mathias M. Weber |
| Physical Description: | Online Resource |
|---|---|
| ISSN: | 1557-3265 |
| DOI: | 10.1158/1078-0432.CCR-24-2461 |